Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 14,161,255Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy's Laboratories

02 1NanoAlvand

03 1Baxter Healthcare Corporation

04 1Chia Tai Tianqing Pharmaceutical Group

05 5Eisai

06 5Eisai Inc

07 1Eisai Pharmaceuticals Africa (Pty) Ltd

08 1GLAND PHARMA LIMITED

09 1JIANGXI QINGFENG

10 1Long Grove Pharmaceuticals

11 1Natco Pharma (Canada) Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Eribulin

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Eribulin Mesylate

Brand Name : Nibulin®

Dosage Form : Solution for Injection

Dosage Strength : 1MG/2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2024-10-01

Application Number : 217250

Regulatory Info : RX

Registration Country : USA

blank

04

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2025-03-04

Application Number : 218743

Regulatory Info : RX

Registration Country : USA

blank

05

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulini mesilas

Brand Name : Halaven

Dosage Form : Inj Solution

Dosage Strength : 1mg/2ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : HALAVEN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2010-11-15

Application Number : 201532

Regulatory Info : RX

Registration Country : USA

blank

11

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

eribulinmesilat

Brand Name : HALAVEN

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 0.44 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

12

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

13

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form : Injection fluid, resolution

Dosage Strength : 0.44 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : HALAVEN

Dosage Form : SOLUTION

Dosage Strength : 0.5MG/ML

Packaging : 2ML

Approval Date :

Application Number : 2377438

Regulatory Info : Prescription

Registration Country : Canada

blank

15

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2024-04-05

Application Number : 218047

Regulatory Info : RX

Registration Country : USA

blank

16

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2024-07-18

Application Number : 214850

Regulatory Info : RX

Registration Country : USA

blank

17

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : NAT-ERIBULIN

Dosage Form : SOLUTION

Dosage Strength : 0.5MG/ML

Packaging :

Approval Date :

Application Number : 2539136

Regulatory Info : Prescription

Registration Country : Canada

blank

18

JIANGXI QINGFENG

Country
STLE Annual Meeting
Not Confirmed
arrow

JIANGXI QINGFENG

Country
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2024-06-28

Application Number : 218281

Regulatory Info : RX

Registration Country : USA

blank

19

Eisai Pharmaceuticals Africa (Pty) ...

Country
STLE Annual Meeting
Not Confirmed
arrow

Eisai Pharmaceuticals Africa (Pty) ...

Country
arrow
STLE Annual Meeting
Not Confirmed

Eribulin Mesilate

Brand Name : Halaven

Dosage Form : INJ

Dosage Strength : 10mg

Packaging : 2X1mg/2ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank